运动神经元是人体内最大的细胞之一。特别是，上运动神经元——从大脑皮层延伸到脑干或脊髓——平均直径为60微米。这些上运动神经元也更容易受到损伤，无论是来自像ALS这样的神经退行性疾病，还是仅仅是自然衰老，都比其他细胞（包括较小的运动神经元）更容易受到损伤，尽管它们的功能相同。（背景延伸：上运动神经元主要负责控制随意运动，其损伤会导致肌肉无力、痉挛等症状。下运动神经元则直接支配肌肉，其损伤会导致肌肉萎 ...

运动神经元是人体内最大的一些细胞。特别是，上运动神经元——从大脑皮层延伸到脑干或脊髓——平均直径为60微米。这些上运动神经元也更容易受到损伤，无论是来自ALS等神经退行性疾病，还是仅仅是自然衰老，都比包括较小运动神经元在内的其他细胞更容易受到损伤，尽管它们执行相同的功能。

用药监测与调整：若患者开始接受利鲁唑治疗，需通过临床观察和肝功能检查密切监测药物不良反应。当患者出现持续性不良反应、处于疾病终末期（接受姑息治疗）或已行气管切开术时，应立即停用利鲁唑。

A new study published in Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for ...

Amyotrophic lateral sclerosis (ALS) is a widespread neurodegenerative disease caused by the loss of neurons that control movement. Although abnormal accumulation of proteins called TDP-43 accompanies ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. Scientists have now suggested a potential ...

People with ALS in the U.S. spend over $47,000 for medical care in the year after diagnosis, more than 3.5 times the average ...

DelveInsight's, “Amyotrophic Lateral Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline ...

Medicare beneficiaries with amyotrophic lateral sclerosis (ALS) were found to have more than 3 times the Medicare expenditures and beneficiary liability of the average Medicare beneficiary.